$XRAY
DENTSPLY SIRONA Inc.

2020 Q2 Form 10-Q Financial Statement

#000081847920000037 Filed on August 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $491.0M $1.009B
YoY Change -51.36% -3.14%
Cost Of Revenue $315.0M $468.6M
YoY Change -32.78% -4.23%
Gross Profit $176.0M $540.8M
YoY Change -67.46% -2.17%
Gross Profit Margin 35.85% 53.58%
Selling, General & Admin $261.0M $430.9M
YoY Change -39.43% -0.3%
% of Gross Profit 148.3% 79.68%
Research & Development $18.00M
YoY Change
% of Gross Profit 10.23%
Depreciation & Amortization $78.90M $82.80M
YoY Change -4.71% -3.38%
% of Gross Profit 44.83% 15.31%
Operating Expenses $279.0M $430.9M
YoY Change -35.25% -0.3%
Operating Profit -$104.0M $67.50M
YoY Change -254.07% -105.85%
Interest Expense $11.00M $8.000M
YoY Change 37.5% -16.67%
% of Operating Profit 11.85%
Other Income/Expense, Net -$5.000M -$12.10M
YoY Change -58.68% -1310.0%
Pretax Income -$120.0M $47.60M
YoY Change -352.1% -104.1%
Income Tax -$24.00M $11.20M
% Of Pretax Income 23.53%
Net Earnings -$95.00M $36.40M
YoY Change -360.99% -103.24%
Net Earnings / Revenue -19.35% 3.61%
Basic Earnings Per Share -$0.44 $0.16
Diluted Earnings Per Share -$0.44 $0.16
COMMON SHARES
Basic Shares Outstanding 218.7M shares 224.2M shares
Diluted Shares Outstanding 218.7M shares 225.7M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.109B $250.0M
YoY Change 343.6% 4.6%
Cash & Equivalents $1.109B $250.1M
Short-Term Investments
Other Short-Term Assets $205.0M $270.0M
YoY Change -24.07% -2.17%
Inventory $548.9M $608.3M
Prepaid Expenses
Receivables $500.0M $700.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.363B $1.828B
YoY Change 29.24% -3.39%
LONG-TERM ASSETS
Property, Plant & Equipment $771.7M $819.6M
YoY Change -5.84% -4.43%
Goodwill $3.227B $3.413B
YoY Change -5.44% -1.3%
Intangibles $2.040B $2.296B
YoY Change -11.16% -9.85%
Long-Term Investments
YoY Change
Other Assets $64.00M $63.00M
YoY Change 1.59% -6.53%
Total Long-Term Assets $6.241B $6.747B
YoY Change -7.5% -2.64%
TOTAL ASSETS
Total Short-Term Assets $2.363B $1.828B
Total Long-Term Assets $6.241B $6.747B
Total Assets $8.604B $8.575B
YoY Change 0.34% -2.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $214.1M $248.1M
YoY Change -13.7% -15.15%
Accrued Expenses $486.9M $524.4M
YoY Change -7.15% -8.85%
Deferred Revenue $25.70M $29.20M
YoY Change -11.99% 11.45%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $56.00M
YoY Change -100.0% -74.31%
Total Short-Term Liabilities $763.0M $880.8M
YoY Change -13.37% -21.2%
LONG-TERM LIABILITIES
Long-Term Debt $2.183B $1.441B
YoY Change 51.44% -9.16%
Other Long-Term Liabilities $472.9M $431.2M
YoY Change 9.67% -1.91%
Total Long-Term Liabilities $2.656B $1.873B
YoY Change 41.82% -7.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $763.0M $880.8M
Total Long-Term Liabilities $2.656B $1.873B
Total Liabilities $3.959B $3.392B
YoY Change 16.7% -7.86%
SHAREHOLDERS EQUITY
Retained Earnings $1.125B $1.262B
YoY Change -10.87% 3.75%
Common Stock $2.600M $2.600M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.416B $2.132B
YoY Change 13.33% -2.07%
Treasury Stock Shares 46.10M shares 40.40M shares
Shareholders Equity $4.643B $5.181B
YoY Change
Total Liabilities & Shareholders Equity $8.604B $8.575B
YoY Change 0.34% -2.8%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$95.00M $36.40M
YoY Change -360.99% -103.24%
Depreciation, Depletion And Amortization $78.90M $82.80M
YoY Change -4.71% -3.38%
Cash From Operating Activities $175.1M $145.1M
YoY Change 20.68% 24.12%
INVESTING ACTIVITIES
Capital Expenditures -$13.20M -$29.60M
YoY Change -55.41% -37.55%
Acquisitions
YoY Change
Other Investing Activities $48.10M $17.80M
YoY Change 170.22% -126.61%
Cash From Investing Activities $34.90M -$11.80M
YoY Change -395.76% -89.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 658.1M -110.3M
YoY Change -696.65% 58.93%
NET CHANGE
Cash From Operating Activities 175.1M 145.1M
Cash From Investing Activities 34.90M -11.80M
Cash From Financing Activities 658.1M -110.3M
Net Change In Cash 868.1M 23.00M
YoY Change 3674.35% -134.43%
FREE CASH FLOW
Cash From Operating Activities $175.1M $145.1M
Capital Expenditures -$13.20M -$29.60M
Free Cash Flow $188.3M $174.7M
YoY Change 7.78% 6.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity File Number
EntityFileNumber
0-16211
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000818479
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Entity Registrant Name
EntityRegistrantName
DENTSPLY SIRONA Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
39-1434669
dei Entity Address Address Line1
EntityAddressAddressLine1
13320 Ballantyne Corporate Place
dei Entity Address City Or Town
EntityAddressCityOrTown
Charlotte
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28277-3607
dei City Area Code
CityAreaCode
844
dei Local Phone Number
LocalPhoneNumber
848-0137
dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
dei Trading Symbol
TradingSymbol
XRAY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
218496392 shares
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
490600000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1009400000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1364900000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1955600000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
314500000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
468600000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
721000000.0 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
915100000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
176100000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
540800000 USD
us-gaap Gross Profit
GrossProfit
643900000 USD
us-gaap Gross Profit
GrossProfit
1040500000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
279100000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
430900000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
672600000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
862800000 USD
CY2020Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
156600000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
1300000 USD
CY2019Q2 us-gaap Restructuring Charges
RestructuringCharges
42400000 USD
us-gaap Restructuring Charges
RestructuringCharges
43800000 USD
us-gaap Restructuring Charges
RestructuringCharges
62900000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-104300000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
67500000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-229100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
114800000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
12300000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
8000000.0 USD
us-gaap Interest Expense
InterestExpense
19000000.0 USD
us-gaap Interest Expense
InterestExpense
16400000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000.0 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
200000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1400000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1300000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4300000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12100000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2900000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1700000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-119900000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47600000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-249600000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
101400000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-24000000.0 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13800000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25800000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-95900000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
36400000 USD
us-gaap Profit Loss
ProfitLoss
-235800000 USD
us-gaap Profit Loss
ProfitLoss
75600000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-500000 USD
CY2019Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-500000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-95400000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
36400000 USD
us-gaap Net Income Loss
NetIncomeLoss
-235300000 USD
us-gaap Net Income Loss
NetIncomeLoss
75600000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218700000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
223700000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218700000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225300000 shares
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-95900000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
36400000 USD
us-gaap Profit Loss
ProfitLoss
-235800000 USD
us-gaap Profit Loss
ProfitLoss
75600000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
73600000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
43700000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-44800000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17300000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-7500000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-9800000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2900000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-8100000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1500000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-900000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-3100000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1800000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
67600000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
34800000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44600000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23600000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-28300000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
71200000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-280400000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
52000000.0 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
100000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
400000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
300000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28400000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
71200000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-280800000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
51700000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1109100000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
404900000 USD
CY2020Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
500200000 USD
CY2019Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
782000000.0 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
548900000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
561700000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
204700000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
251300000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
2362900000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1999900000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
771700000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
802400000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
138800000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
159300000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2039600000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2176300000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
3227200000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3396500000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64000000.0 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68500000 USD
CY2020Q2 us-gaap Assets
Assets
8604200000 USD
CY2019Q4 us-gaap Assets
Assets
8602900000 USD
CY2020Q2 us-gaap Debt Current
DebtCurrent
300000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
214100000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
307900000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
486900000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
629200000 USD
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
61700000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
56100000 USD
CY2019Q4 us-gaap Debt Current
DebtCurrent
2300000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
763000000.0 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
995500000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2182700000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1433100000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
101000000.0 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
119500000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
439200000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
479600000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
472900000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
480300000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
3958800000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
3508000000.0 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
2600000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
2600000 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000.0 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000.0 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
264500000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
264500000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
218400000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
221300000 shares
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6576700000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6586700000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1124700000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1404200000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-644700000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-599700000 USD
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
46100000 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
43200000 shares
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2416200000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2301300000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4643100000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5092500000 USD
CY2020Q2 us-gaap Minority Interest
MinorityInterest
2300000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
2400000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4645400000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5094900000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8604200000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8602900000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5094900000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-139900000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-112200000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3800000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9400000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
2100000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
140000000.0 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6100000 USD
CY2020Q1 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
0 USD
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1000
CY2020Q1 us-gaap Dividends Cash
DividendsCash
21800000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4690200000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-95900000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
67600000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1600000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10300000 USD
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6500000 USD
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1000
CY2020Q2 us-gaap Dividends Cash
DividendsCash
21900000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4645400000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5133000000.0 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
39200000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-58400000 USD
CY2019Q1 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
10400000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19700000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9100000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
2000000.0 USD
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4800000 USD
CY2019Q1 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
0 USD
CY2019Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.0875
CY2019Q1 us-gaap Dividends Cash
DividendsCash
19900000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5109500000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
36400000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
34800000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56500000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25200000 USD
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
60000000.0 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-100000 USD
CY2019Q2 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
0 USD
CY2019Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.0875
CY2019Q2 us-gaap Dividends Cash
DividendsCash
19400000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5182900000 USD
us-gaap Profit Loss
ProfitLoss
-235800000 USD
us-gaap Profit Loss
ProfitLoss
75600000 USD
us-gaap Depreciation
Depreciation
64500000 USD
us-gaap Depreciation
Depreciation
70400000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
93800000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
95500000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1800000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1400000 USD
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
33200000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
156600000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
38700000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
5300000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-32400000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-18400000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
19700000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
34400000 USD
us-gaap Restructuring Costs
RestructuringCosts
4500000 USD
us-gaap Restructuring Costs
RestructuringCosts
14800000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3700000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
16700000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-600000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-600000 USD
xray Gain Loss On Disposal Of Non Controlling Interest
GainLossOnDisposalOfNonControllingInterest
0 USD
xray Gain Loss On Disposal Of Non Controlling Interest
GainLossOnDisposalOfNonControllingInterest
8700000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-14500000 USD
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-268700000 USD
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
1500000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1000000.0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18300000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-33000000.0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7900000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-5900000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-6900000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-88700000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-32200000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-138600000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-81100000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-14600000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-11000000.0 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-8600000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1800000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
164400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
174400000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
38800000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
63500000 USD
xray Cash Paid On Sale Of Non Strategic Business Or Product Lines
CashPaidOnSaleOfNonStrategicBusinessOrProductLines
0 USD
xray Cash Paid On Sale Of Non Strategic Business Or Product Lines
CashPaidOnSaleOfNonStrategicBusinessOrProductLines
11600000 USD
us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
57500000 USD
us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
27000000.0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
300000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
700000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
700000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19400000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24500000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-1200000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-23300000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
140000000.0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
60000000.0 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
44000000.0 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
39100000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1448400000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1700000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
700900000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
134600000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
6300000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5400000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
76400000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
2700000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
30600000 USD
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
30500000 USD
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
528200000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-209500000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7800000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
704200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-59500000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
404900000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
309600000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1109100000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250100000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates, and such differences may be material to the consolidated financial statements.</span></div>
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1109100000 USD
xray Debt Instrument Covenant Operating Income Excluding Depreciation And Amortization To Interest Expense Minimum
DebtInstrumentCovenantOperatingIncomeExcludingDepreciationAndAmortizationToInterestExpenseMinimum
3.0
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
25700000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9900000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24900000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19100000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33800000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1100000 USD
CY2019Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3600000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2100000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5000000.0 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9900000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19100000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24900000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33800000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-95400000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
36400000 USD
us-gaap Net Income Loss
NetIncomeLoss
-235300000 USD
us-gaap Net Income Loss
NetIncomeLoss
75600000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218700000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
223700000 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-95400000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
36400000 USD
us-gaap Net Income Loss
NetIncomeLoss
-235300000 USD
us-gaap Net Income Loss
NetIncomeLoss
75600000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218700000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
223700000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1500000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1600000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218700000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225300000 shares
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2020Q2 xray Potentially Dilutive Securities Excluded From Computation Of Earnings Amount
PotentiallyDilutiveSecuritiesExcludedFromComputationOfEarningsAmount
700000 shares
xray Potentially Dilutive Securities Excluded From Computation Of Earnings Amount
PotentiallyDilutiveSecuritiesExcludedFromComputationOfEarningsAmount
1000000.0 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4200000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3100000 shares
CY2020Q1 xray Accelerated Share Repurchases Authorized Amount
AcceleratedShareRepurchasesAuthorizedAmount
140000000.0 USD
CY2020Q1 us-gaap Accelerated Share Repurchases Settlement Payment Or Receipt
AcceleratedShareRepurchasesSettlementPaymentOrReceipt
140000000.0 USD
CY2020Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2700000 shares
CY2020Q1 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
42.12
CY2020Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1000000.0 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
490600000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1009400000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1364900000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1955600000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-119900000 USD
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
22500000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
548900000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
561700000 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
102000000.0 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
85000000.0 USD
CY2020Q2 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
1300000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
43800000 USD
CY2019Q2 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
42400000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
62900000 USD
CY2020Q2 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47600000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-249600000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
101400000 USD
CY2020Q2 us-gaap Lifo Inventory Amount
LIFOInventoryAmount
7900000 USD
CY2019Q4 us-gaap Lifo Inventory Amount
LIFOInventoryAmount
5000000.0 USD
CY2020Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
15900000 USD
CY2019Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
14300000 USD
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
322300000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
356400000 USD
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
78800000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
82500000 USD
CY2020Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
147800000 USD
CY2019Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
122800000 USD
CY2020Q2 us-gaap Derivative Assets
DerivativeAssets
22500000 USD
CY2020Q2 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
1600000 USD
CY2020Q2 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
20900000 USD
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1900000 USD
CY2020Q2 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2020Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1900000 USD
CY2020Q2 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
1600000 USD
CY2020Q2 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
300000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
45700000 USD
CY2019Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2019Q4 us-gaap Derivative Assets
DerivativeAssets
45700000 USD
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
8700000 USD
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
37000000.0 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
14000000.0 USD
CY2019Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2019Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
14000000.0 USD
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
8700000 USD
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
5300000 USD
CY2020Q2 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
900000 USD
CY2019Q2 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
1800000 USD
CY2019Q2 xray Effective Income Tax Rate Reconciliation Indefinite Lived Intangible Asset Impairment Charges
EffectiveIncomeTaxRateReconciliationIndefiniteLivedIntangibleAssetImpairmentCharges
-10100000 USD
CY2020Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
1156100000 USD
us-gaap Number Of Reporting Units
NumberOfReportingUnits
5 reportingUnit
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1528400000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3396500000 USD
xray Goodwill Impairment Loss Excluding Foreign Exchange Rate
GoodwillImpairmentLossExcludingForeignExchangeRate
156600000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-12700000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
3227200000 USD
CY2020Q2 us-gaap Goodwill Gross
GoodwillGross
6120400000 USD
CY2020Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
2893200000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
3227200000 USD
CY2019Q4 us-gaap Goodwill Gross
GoodwillGross
6133100000 USD
CY2019Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
2736600000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3396500000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2530200000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1100200000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1430000000.0 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2536800000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1008400000 USD
CY2020Q2 xray Identifiable Intangible Assets Gross
IdentifiableIntangibleAssetsGross
3139800000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1100200000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2039600000 USD
CY2019Q4 xray Identifiable Intangible Assets Gross
IdentifiableIntangibleAssetsGross
3184700000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1008400000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2176300000 USD
CY2018Q1 xray Employment Agreement Terms Minimum Period Of Employment
EmploymentAgreementTermsMinimumPeriodOfEmployment
P8Y
CY2018Q2 xray Number Of Class Action Lawsuits
NumberOfClassActionLawsuits
2 performancePeriods
CY2018Q2 xray Number Of Distributors
NumberOfDistributors
3 performancePeriods
CY2019Q2 xray Number Of Stockholders Who Filed Derivative Action
NumberOfStockholdersWhoFiledDerivativeAction
2 performancePeriods
CY2014Q1 xray Effective Income Tax Rate Reconciliation Deduction Worthless Stock Amount
EffectiveIncomeTaxRateReconciliationDeductionWorthlessStockAmount
546000000.0 USD

Files In Submission

Name View Source Status
0000818479-20-000037-index-headers.html Edgar Link pending
0000818479-20-000037-index.html Edgar Link pending
0000818479-20-000037.txt Edgar Link pending
0000818479-20-000037-xbrl.zip Edgar Link pending
exhibit101q22020.htm Edgar Link pending
exhibit102q22020.htm Edgar Link pending
exhibit103q22020.htm Edgar Link pending
exhibit311q22020.htm Edgar Link pending
exhibit312q22020.htm Edgar Link pending
exhibit32q22020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xray-20200630.htm Edgar Link pending
xray-20200630.xsd Edgar Link pending
xray-20200630_cal.xml Edgar Link unprocessable
xray-20200630_def.xml Edgar Link unprocessable
xray-20200630_htm.xml Edgar Link completed
xray-20200630_lab.xml Edgar Link unprocessable
xray-20200630_pre.xml Edgar Link unprocessable